Core Points - The event themed "Industrial Innovation and New Momentum" marked the official opening of the core commercial facilities in the Zhongguancun Industrial Internet Industrial Park, highlighting a strategic partnership between the Industrial Internet Company and Beijing Shijingshan Cultural Tourism Company [1][2] - The strategic cooperation agreement aims to enhance regional industrial services and contribute to high-quality economic development by integrating technology and cultural tourism [2] - The park's commercial street is positioned as a new consumption destination, emphasizing its potential to support the park's ecosystem and enhance regional value [1][2] Summary by Sections Event Overview - The opening ceremony was attended by representatives from government departments, businesses, and the media, showcasing the significance of the commercial street's launch and the strategic partnership [1] - The event included a speech by the general manager of the Industrial Internet Company, who highlighted the importance of commercial facilities in improving the park's ecosystem and employee services [1] Strategic Partnership - The signing of the strategic cooperation agreement was a key highlight, with both companies aiming to leverage their strengths for mutual development [2] - The partnership will focus on providing comprehensive business services, including cultural and sports services, conference exhibitions, and team-building activities [2] Future Development - The commercial street will enhance its service offerings and diversify its business types, creating a vibrant space that integrates work, life, and leisure [3] - This initiative is expected to attract quality merchants and consumers, thereby stimulating economic growth in the Shijingshan West area [3]

Core Insights - The opening of the Zhongguancun Industrial Internet Industry Park commercial street represents a significant showcase of commercial brands and service capabilities, establishing a foundation for "service upgrade + resource integration" through a strategic partnership with Jing Shi Cultural Tourism [1] Group 1: Industry Development - The Zhongguancun Industrial Internet Industry Park is a key driver of industrial internet development in Beijing, attracting over 40 major industry enterprises [1] - The commercial street has successfully introduced various brands, including KFC, Kudi Coffee, Jiahe Yipin, Niudinghong Ramen, and Aixingda Grilled Fish [1] Group 2: Future Plans - The general manager of the industrial internet company emphasized the importance of commercial support in enhancing the park's ecosystem, serving employees, and increasing regional value [1] - Future plans for the commercial street include diversifying business formats and improving service quality to create a vibrant space that integrates work, life, and leisure, aiming to attract quality merchants and consumers [1] Group 3: Strategic Collaboration - The chairman of Jing Shi Cultural Tourism highlighted the company's efforts to expand one-stop business services, covering corporate cultural and sports services, conferences, exhibitions, and team-building activities [1] - Jing Shi Cultural Tourism aims to upgrade the park's commercial services towards high-end and customized offerings, collaborating with the industrial internet company to build a new ecosystem that deeply integrates "industry + service," injecting new vitality into park enterprises and contributing to regional economic development [1]

Core Viewpoint - Zhongguancun (000931.SZ) announced that its subsidiary Beijing Huasu Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for the drug "Naltrexone Hydrochloride Tablets" (50mg), which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Company Summary - Beijing Huasu has successfully obtained the approval notice (Notification No. 2025B04969) for its Naltrexone Hydrochloride Tablets, indicating compliance with regulatory standards [1] - The drug is intended to block the pharmacological effects of exogenous opioid substances and serves as an auxiliary medication for preventing relapse in opioid-dependent individuals after detoxification [1]

关于下属公司北京华素盐酸纳曲酮片通过一致性评价的公告 共 3 页 证券代码：000931 证券简称：中关村 公告编号：2025-124 北京中关村科技发展（控股）股份有限公司 关于下属公司北京华素盐酸纳曲酮片通过一致性评价的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 北京中关村科技发展（控股）股份有限公司（以下简称：公司）于 2024 年 9 月披露《关于下属公司北京华素盐酸纳曲酮片一致性评价申报收到国家药品监 督管理局<受理通知书>的公告》（公告编号：2024-080）。 近日，公司下属公司北京华素制药股份有限公司（以下简称：北京华素）收 到国家药品监督管理局核准签发的《药品补充申请批准通知书》（通知书编号： 2025B04969），获悉，北京华素生产的"盐酸纳曲酮片"（规格：50mg）通过了 仿制药质量和疗效一致性评价。具体情况如下： 一、批件主要内容 药品名称：盐酸纳曲酮片 注册商标：诺欣生® 剂型：片剂 规格：50mg 包装规格：30 片/瓶 申请内容：仿制药质量和疗效一致性评价 审批结论：根据《中华人民共和国药品管理法》、《国务院关于改革药 ...

Core Viewpoint - The company Beijing Huasu Pharmaceutical Co., Ltd. has successfully passed the consistency evaluation of quality and efficacy for its generic drug, "Sodium Naltrexone Tablets" (50mg) [1] Group 1: Product Information - The drug is named Sodium Naltrexone Tablets, with a registered trademark of Noxins [1] - The dosage form is a tablet, with a specification of 50mg [1] - The registration category is classified as a chemical drug, with acceptance number CYHB2450481 and notification number 2025B04969 [1] - The packaging specification is 30 tablets per bottle [1] Group 2: Regulatory Approval - The approval conclusion states that the product has passed the consistency evaluation of quality and efficacy according to relevant regulations [1] - The marketing authorization holder and manufacturing enterprise is Beijing Huasu Pharmaceutical Co., Ltd. [1]

Core Viewpoint - Zhongguancun (000931.SZ) announced that its subsidiary Beijing Huasu Pharmaceutical Co., Ltd. received approval from the National Medical Products Administration for the "Supplementary Application Approval Notice" for its product, "Naltrexone Hydrochloride Tablets" (50mg), which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1: Product Information - Naltrexone hydrochloride can block the pharmacological effects of exogenous opioids and is used as an auxiliary drug for preventing relapse after detoxification in opioid-dependent individuals [1] - The original manufacturer of Naltrexone is TEVA WOMENS, which was approved for marketing in the U.S. in 1984 under the brand name REVIA, with a tablet form and a specification of 50mg [1] - Currently, there are no original or imported generic drugs of this product in the domestic market, with only Beijing Huasu having launched this product in specifications of 5mg and 50mg, registered under the trademark Noxins® [1] Group 2: Market Position - Beijing Huasu's Naltrexone hydrochloride tablets (50mg) are the first product to pass the consistency evaluation in this category [1] - As of the date of the announcement, a total of 11.7389 million yuan has been invested in the research and development of the consistency evaluation project for Naltrexone hydrochloride tablets [1]

Core Viewpoint - The company Beijing Huasu Pharmaceutical Co., Ltd. has successfully passed the consistency evaluation of quality and efficacy for its generic drug, "Sodium Naltrexone Tablets" (50mg) [1] Group 1: Product Information - The drug is named Sodium Naltrexone Tablets, with a registered trademark of Noxins® [1] - The dosage form is a tablet, with a specification of 50mg [1] - The registration category is classified as a chemical drug, with acceptance number CYHB2450481 and notification number 2025B04969 [1] - The packaging specification is 30 tablets per bottle [1] Group 2: Regulatory Approval - The approval conclusion states that the product has passed the consistency evaluation of quality and efficacy according to relevant regulations [1]

Core Insights - Zhongguancun is actively building a corporate matrix characterized by strong large enterprises, numerous unicorns, and vibrant small and medium-sized enterprises, with 31 innovation consortia and technology innovation centers established to support leading tech firms and hard-tech unicorns [1][2] - In 2024, Zhongguancun is projected to have 20,800 national high-tech enterprises, 532 listed companies, and 93 unicorns, with an average of 40,000 new tech companies established annually since the 14th Five-Year Plan, representing a 40% increase compared to the previous five-year period [1] Financial Performance - The total revenue of Zhongguancun enterprises is expected to approach 10 trillion yuan in 2024, which is 1.4 times that of 2020, accounting for one-sixth of the national high-tech zones and approximately one-third of Beijing's GDP [1] Innovation and Technology - Zhongguancun has made significant breakthroughs in its role as a "testbed" for technology system reforms, implementing 24 new reform measures and over 50 supporting policies, with pilot measures being deployed nationwide [2] - The region is leading in artificial intelligence, with a comprehensive strength ranking among the top globally, having established the world's first AI district and registering 136 large models, which constitutes 25.2% of the national total [2] Ecosystem and Collaboration - Zhongguancun has established over 10,000 branch offices in the Beijing-Tianjin-Hebei region, enhancing its open innovation ecosystem and leading the entrepreneurial incubation into its 4.0 phase with 25 benchmark incubators [3] - The area hosts 116 regional headquarters of multinational companies and 230 foreign R&D centers, solidifying its position as a global innovation network hub [3]

Core Viewpoint - The establishment of a merger and acquisition (M&A) restructuring and development service platform led by the Beijing Listed Companies Association aims to enhance the quality of the Beijing M&A market through technological empowerment and ecological collaboration [1][2]. Group 1: Platform Design and Security - The platform prioritizes information security and compliance in its design, employing multiple desensitization techniques such as encryption algorithms and fuzzification to ensure the safe sharing of commercial information [1]. - The platform adheres to regulatory requirements from the Beijing Financial Office and the Beijing Securities Regulatory Bureau, ensuring a controlled environment for sensitive information [1]. Group 2: Growth and Resource Integration - The platform leverages the advantages of the Zhongguancun Development Group, which operates 73 specialized parks and serves over 22,600 enterprises, to identify high-growth technology companies [2]. - The group manages a fund size of 55.7 billion yuan, focusing on key national industries such as integrated circuits, artificial intelligence, and healthcare [2]. Group 3: Financial Support and Innovation - Zhongguancun Jinfu plans to collaborate with banks, securities firms, and trusts to innovate financial tools like M&A loans and targeted convertible bonds, providing customized financial support for transactions [2]. - The company aims to establish a "patient capital" system by exploring the creation of M&A funds in collaboration with financial institutions and leading enterprises [3]. Group 4: Future Outlook - Over the next three years, Zhongguancun Jinfu will focus on providing comprehensive financial services throughout the M&A activity cycle, utilizing its integrated financial service system [2]. - The company aims to build a new ecosystem for M&A services that encompasses technology, capital, parks, and policies, contributing to the development of a globally influential technology innovation center in Beijing [3].

GUOTE INSTItuTion REPORT 房地产抵押估价报告 估价报告编号: 深国策估字 FBJ[2025]100021 号 估价项目名称:北京市朝阳区左家庄中街6号院9号 楼-2 层 2-001 等 72个车位房地产抵 押价值评估 估价委托人:南京银行股份有限公司北京分行 房地产估价机构:深圳市国策房地产土地资产评估有限公司 注册房地产估价师: 金晓飞 (注册证书编号: 1120130047) 刘丽佳（注册证书编号: 3720130016) 估价报告出具日期: 2025 年 10 月 27 日 防伪编码:20251003360 防伪查询请登录"国策评估"网站:www.guocedc.com 专业 服 务 · 创 造 价值 致估价委托人函 南京银行股份有限公司北京分行: 承蒙委托,我公司对位于北京市朝阳区左家庄中街６号院９号楼-2 层 2-001 等 72个车位房地产在现状利用条件下的抵押价值进行了评估。估价对象及估价摘要如 下： 1、估价对象基本情况:根据权利人提供的《房屋所有权证》,估价对象为北京 市朝阳区左家庄中街６号院９号楼-2 层 2-001 等 72 个车位用途房地产,建筑面积合 计为 3 ...